What is the purpose of this trial?
The study objective is to demonstrate that the safety and effectiveness of the Medtronic TAVR system as measured by rates of all-cause mortality or disabling stroke at two years is noninferior to SAVR in the treatment of severe aortic stenosis in subjects who have a low predicted risk of operative mortality for SAVR.
Ages: 18 years and older
Dates: 07/29/2016 - 12/31/2016
Last Updated: 02/22/2018
Study HIC#: 1603017500